Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	151.38	251.43	100.02
Graham Fair Price	-16.81	21.74	26.13
PEG	-38.88	0.27	-0.43
Price/Book	-12.50	2.08	2.37
Price/Cash Flow	128.45	27.10	11.86
Prices/Earnings	26.30	-44.92	35.57
Price/Sales	-2.35	5.32	5.45
Price/FCF	128.45	27.10	11.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-10.13	0.44	0.49
Operating Margin	-12.15	-0.03	0.03
ROA	-30.40	< 0.005	< 0.005
ROE	0.02	-0.01	-30.72
ROIC	< 0.005	< 0.005	-4.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.09	80.83
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.90	-1.79	-99.24
EPS QOQ	-0.82	-1.69	-106.63
FCF QOQ	2.77	-0.62	-77.73
Revenue QOQ	-0.23	-0.10	54.23
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	43.87	53.77	22.59
Days Sales Outstanding (DSO)	60.03	75.56	25.87
Inventory Turnover	2.05	1.67	-18.43
Debt/Capitalization	0.58	0.62	5.87
Quick Ratio	0.26	0.30	14.18
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	42.65	42.63	-0.05
Cash	0.13	0.70	455.67
Capex	-0.36	-0.46	-26.55
Free Cash Flow	8.53	3.27	-61.72
Revenue	18.56	16.62	-10.45
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.45	2.56	4.19
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	40.94	109.51	167.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating